Clinical Trials Logo

Clinical Trial Summary

THALES-EVAQUAL study assesses the quality of the images generated by C-ARM ARCO FP-Rk521S and its ability to be used during surgery.


Clinical Trial Description

Expected performance of TED developped technology compared to current equipment (intensifier tube) represent a significant improvement; especially in term of image rendering, irradiation dose reduction and ergonomy.

THALES-EVAQUAL is a prospective,monocentric, unrandomized, and uncontrolled study which objective is to assess C-ARM ARCO FP-Rk521S in term of quality of image. It also evaluates its ability to be used during Orthopedic, neurological and neurological surgeries.

Patient included in the study will have a surgery during which C-ARM is used. This study doesn't modify the medical care of the patient.

After each surgery, a digital scale of image quality will be filled by the surgeon for each aquisition. Other feedback questionnaires regarding the suitability of the device and the satisfaction of the surgeon will also be completed. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03241290
Study type Observational
Source University Hospital, Grenoble
Contact
Status Completed
Phase
Start date May 29, 2017
Completion date January 30, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT02798068 - Steroids and Microcirculation In Cardiac Surgery Phase 4
Completed NCT04172662 - Music Therapy as an Adjunct in CIED Lead Extraction Procedures N/A